Advisor Group Holdings, Inc. Blueprint Medicines Corp Transaction History
Advisor Group Holdings, Inc.
- $67.1 Billion
- Q3 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 23 shares of BPMC stock, worth $2,977. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 278
91.73%
Holding current value
$2,977
Previous $35,000
94.29%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding BPMC
# of Institutions
40Shares Held
8.54MCall Options Held
0Put Options Held
14.8K-
Black Rock Inc. New York, NY6.65MShares$861 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8724KShares$93.7 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL419KShares$54.3 Million0.01% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL155KShares$20 Million0.09% of portfolio
-
Ghost Tree Capital, LLC New York, NY140KShares$18.1 Million4.85% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...